Dual immunotherapy with neoadjuvant chemotherapy shows encouraging activity in ERBB2-negative breast cancerJuly 30, 2026
Tech Silicon Valley Medical Technology Startup Earns Spot on Nasdaq ToBy Healthcare Propulsion StaffJuly 30, 20260 TibaRay brings together expertise in physics, engineering, and medicine to advance the future of radiation technology. TibaRay appears among the…